Investment Firm
Overview
Lys Therapeutics develops drugs to treat patients suffering from neurovascular or neurodegenerative disorders.
May 15, 2023
Non Equity Assistance
Highlights
Location
Social
Investor Lead
N/A
Participant Investors
1
Investor Name |
---|
Normandie Incubation |
Lys Therapeutics raised an undisclosed amount on 2023-05-15 in Non Equity Assistance
Lys Therapeutics develops drugs to treat patients suffering from neurovascular or neurodegenerative disorders.
Company Funding History
5
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Nov 14, 2022 | Debt Financing - Lys Therapeutics | 1 | - | 2.6M |
Mar 15, 2023 | Grant - Lys Therapeutics | 1 | - | 600.0K |
Mar 31, 2021 | Non Equity Assistance - Lys Therapeutics | 2 | - | undefined |
May 15, 2023 | Non Equity Assistance - Lys Therapeutics | 1 | - | undefined |